Generalized Anxiety Disorder (GAD): Diagnosis and Treatment

GAD is characterized by excessive, uncontrollable worry about multiple domains for ≥6 months, with associated somatic symptoms.

Diagnostic Criteria (DSM-5)

  • Excessive anxiety/worry more days than not × 6 months.
  • Difficult to control.
  • ≥3 of: restlessness, fatigue, concentration difficulty, irritability, muscle tension, sleep disturbance.
  • Clinically significant distress/impairment.
  • Not due to substance/medical condition/other mental disorder.

Treatment

  • First-line psychotherapy: CBT — cognitive restructuring, worry exposure, relaxation training, problem-solving. High efficacy, durable.
  • First-line pharmacotherapy: SSRIs (escitalopram, sertraline, paroxetine) or SNRIs (venlafaxine, duloxetine). 4–8 weeks for full effect.
  • Adjunctive: Buspirone (partial 5-HT1A agonist), pregabalin (in some guidelines), short-term benzodiazepines (only if severe, non-response to others — dependence risk).
  • Lifestyle: Exercise, sleep hygiene, caffeine/alcohol reduction, mindfulness.

Prognosis

Chronic but treatable. Remission rates 40–60% with adequate treatment. Combined therapy (CBT + med) often superior. Relapse prevention requires maintenance treatment.

Illness - Related Articles